Delvens published a new research publication on "Percutaneous Coronary Intervention Market Insights, to 2030" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the percutaneous coronary intervention market was mainly driven by the increasing R&D spending across the world.
The global percutaneous coronary intervention market is anticipated to reach USD 16.7 billion by 2020 growing at a CAGR of 7.2% during the forecasting period to 2028.
Get Free Sample Report: https://www.delvens.com/get-free-sample/percutaneous-coronary-intervention-market
Percutaneous Coronary Intervention is a non-invasive procedure that is used for treating the narrowing arteries of the heart in coronary artery diseases including angina, acute myocardial infarction, and multivessel coronary artery disease (CAD). Factors such as rising risk factors associated with heart diseases such as obesity, smoking, and substance abuse, fatty foods, etc and rising geriatric and pediatric population are some of the major drivers for the market of percutaneous coronary intervention.
Key players in global percutaneous coronary intervention market:
· Abbott,
· Asahi Intecc Company Limited,
· B. Braun Melsungen AG,
· Biosensors International Group, Ltd.,
· Biotronik,
· Boston Scientific Corporation,
· C. R. Bard, Inc.,
· Comed B.V.,
· Cook,
· Cordis,
· Medtronic,
· Merit Medical System,
· Terumo Corporation,
· Philips Healthcare among others
Recent Developments
The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:
In 2019, Abbott has announced to acquire Cephea Valve Technologies Inc., which is engaged in developing a minimally invasive mitral valve replacement system.
In 2018, Medtronic has announced the launch of the first 2.0 mm Drug-Eluting Stent in the United States designed to treat patients with small vessels
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/percutaneous-coronary-intervention-market
The global percutaneous coronary intervention market is segmented into type, technique, disease, end-user, and geography.
The type segment is segmented into Balloon Angioplasty, Angioplasty with Stent, Laser Angioplasty, Rotational Atherectomy, CTO (Chronic Total Occlusions), Coronary Guidewires, Coronary Stents, PTCA Catheters, Embolic Protection Devices (EPDs). Balloon Angioplasty segment is further segmented into Aorta, Iliac Artery, Femoral Artery, Popliteal Artery, Tibial and Peroneal Arteries.
Angioplasty with Stent is further segmented into Dual Therapy Stent, Bioresorbable Vascular Scaffold, Bio-Engineered Stent, Drug-Eluting Stent, and bare-metal stent. The Rotational Atherectomy segment is further segmented into Low-Speed Rotational Atherectomy, High-Speed Rotational Atherectomy. CTO (Chronic Total Occlusions) segment is further segmented into Retrograde Technique, Anterograde Technique with Wire Scaling, Anterograde Dissection, and Reentry Technique and Others.
Techniques are segmented into Advanced Imaging, Fractional Flow Reserve (FRR), and Radial Artery Access
The disease is segmented into Angina, Myocardial Infraction (MI), Multivessel Coronary Artery Disease (CAD). Angina is further segmented into Unstable Angina, Stable Angina. Myocardial Infraction is further segmented into Acute Non-ST Elevation Myocardial Infarction, Acute ST-Elevation Myocardial Infarction. Multivessel Coronary Artery Disease is further segmented into Obstructive Coronary Artery Disease and Spontaneous Coronary Artery Dissection (SCAD).
End-User is segmented into Hospital, Cardiac Centers, Ambulatory Surgical Centers, Specialty Centers, Cath Labs, and Others
The Report helps to identify the opportunities in Global Regions:
· North America (the United States, Canada, and Mexico)
· Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
· Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
· South America (Brazil etc.)
· The Middle East and Africa (North Africa and GCC Countries)
Access Full Report: https://www.delvens.com/report/percutaneous-coronary-intervention-market
In addition to the market data for the percutaneous coronary intervention market, Delvens. offers client-centric reports and customized according to the company’s specific demand and requirement.
Reasons to Acquire
· Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
· Gain authentic and granular data access for the percutaneous coronary intervention market so as to understand the trends and the factors involved behind changing market situations
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Access More Reports:
Peripheral Intervention Market
Real-World Evidence (RWE) Solutions Market
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
